The effect of cardiopulmonary bypass (CPB) on the production of prostacyclin and thromboxane was studied. Sixteen patients, who had undergone CPB with bubble oxygenator, roller pump and moderate hypothermia, were examined. We collected serial plasma samples and assayed them for thromboxane B2 (TXB2) and 6-keto-Prostaglandin Fla (6-keto-PGFIa) by radioimmunoassay, the main metabolites of thromboxane A2 and prostacyclin respectively.
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And twelve mongolian dogs were studied experimentally. They had undergone normothermic CPB with bubble oxygenator and roller pump for 120 minutes. Serial plasma samples were assayed with same method.
In the clinical study, TXB2 and 6-keto-PGFIa increased significantly during CPB. The ratio of two prostanoids (6-keto-PGFIa/TXB2) did not changed in many of the cases. In experimental study of dogs, TXB2 increased significantly on the commencement of CPB. 6-keto-PGFIa increased gradually and continuously during CPB. The ratio of two prostanoids (6-keto-PGFIa/TXB2) elevated at the post CPB phase as a result. 6-keto-PGFIa did not increased in three clinical cases despite of elevated TXB2. These cases are not ideal from the view point of prostanoid balance during CPB. 
